Cardiac Care in pa+ents with Duchenne muscular dystrophy

Similar documents
The Heart Is A Muscle Too! The Cardiomyopathy In Duchenne Muscular Dystrophy

Cardiac Health in Duchenne: What we are Learning from Cardiac MRI

Cardiac Considerations and Care in Children with Neuromuscular Disorders

State-of-the-Art Management of Chronic Systolic Heart Failure

Left ventricular non-compaction: the New Cardiomyopathy on the Block

DILATED CARDIOMYOPATHY

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Topic Page: congestive heart failure

Heart Failure. GP Update Refresher 18 th January 2018

DMD/BMD Carrier Symposium PPMD Annual Conference June 29, 2018

Congestive Heart Failure or Heart Failure

Checklist for Treating Heart Failure. Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute

This information explains heart failure, including causes and signs of heart failure, how heart failure is diagnosed, and how it s treated.

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology

Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None

Module 1: Evidence-based Education for Health Care Professionals

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

What s new in Hypertrophic Cardiomyopathy?

cardiomyopathy. INTRODUCTION NONISCHEMIC CARDIOMYOPATHY

In Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison

9/23/2011. Cardiac MRI Evaluation of Cardiomyopathy and Myocarditis. Primary Hypertrophic Cardiomyopathy. Cardiomyopathy.

Management Strategies for Advanced Heart Failure

Module 1: Evidence-based Education for Health Care Professionals

RESTRICTIVE CARDIOMYOPATHY

8:30-10:30 WS #4: Cardiology :00-13:00 WS #11: Cardiology 101 (Repeated)

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Two Cardiology Zebras ERIC MARTIN MD

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Make you feel better Make you live longer

Different indications for pacemaker implantation are the following:

Heart Failure with Preserved Ejection Fraction: Mechanisms and Management

Living well with Heart Failure. Annabel Sturges Heart Failure Specialist Nurse Frimley Park Hospital

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

Structure and organization of blood vessels

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification

EVALUATION. When is a Heart Transplanted?

Heart Failure. Symptoms and Treatments. FloridaHospital.com

Device Therapy for Heart Failure

Heart Failure in 2012 with reference to NICE Guidance Dr Maurice Pye Consultant Cardiologist York District Hospital

Congestive Heart Failure

Effects of heart rate reduction with ivabradine on left ventricular remodeling and function:

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Objectives. Outline 4/3/2014

Treatment of Cardiac Disease in Propionic Acidemia

Endurance Exercise and Cardiovascular Health

Cardiac Disease in Fatty Acid Oxidation Disorders

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

Diastolic Dysfunction: Hypertension to Hypertrophy to Heart Failure

Take-home Messages from Recent Heart Failure Trials: Heart Rate as a Target

Outline. Chronic Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.

Chronic. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Michael G. Shlipak, MD, MPH

HEART CONDITIONS IN SPORT

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.

Why guess when you could know? Gold Standard. Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.

Ejection Fraction in Patients With Chronic Heart Failure. Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction

Collin County Community College

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Special health. guide. Hugh Calkins, M.D., and Ronald Berger, M.D., Ph.D. Guide to Understanding. Atrial Fibrillation WITH

Understanding and Development of New Therapies for Heart Failure - Lessons from Recent Clinical Trials -

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia

HYPERTROPHIC CARDIOMYOPATHY

Myocardial Infarction. Reading Assignment (p66-78 in Outline )

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

The NEW Heart Failure Guidelines

Acute Myocarditis Mimicking ST-segment Elevation Myocardial Infarction: Relation Between ECG Changes And Myocardial Damage As Assessed By CMR

WHAT S NEW IN HEART FAILURE

Heart Failure (HF) Treatment

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

Heart Failure. Dr. William Vosik. January, 2012

Recommended Evaluation Data Excerpt from NVIC 04-08

Susan P. D Anna MSN, APRN BC February 14, 2019

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

Heart Failure from a GP perspective

Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients

HEART FAILURE: PHARMACOTHERAPY UPDATE

27-year-old professionnal rugby player: asymptomatic

Case based learning: CMR in Heart Failure

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Congestive Heart Failure: Outpatient Management

Pediatric pacemakers & ICDs:

Acute Myocardial Infarction

THE CARDIOVASCULAR SYSTEM

Treatment of Hypertrophic Cardiomyopathy in Bruce B. Reid, MD

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Heart Failure A Disease for the Internist?

The Causes of Heart Failure

Dr Navin Chandra Clinical Research Fellow in Cardiology St George s University of London

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation

Effects of heart rate reduction with ivabradine on left ventricular remodeling and function:

Heart Failure Medical and Surgical Treatment

Mission Statement for our Arrhythmia Care

Cardiovascular System

A Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE

Transcription:

Cardiac Care in pa+ents with Duchenne muscular dystrophy Linda Cripe, M.D. Professor of Pediatrics The Heart Center....

Why are cardiologists interested in patients with Duchenne muscular dystrophy?....

The Heart is a Muscle TOO!!!....

Care of the individual with DMD is a team sport....

Questions we will answer today 1. What does cardiomyopathy mean? 2. What does heart failure mean? 3. Who should care for the heart? 4. When should cardiac care begin? 5. How will the heart be checked? 6. What should I watch for? 7. What treatment is available? 8. Should carriers have their hearts checked?

1. What does cardiomyopathy mean? The normal heart....

1. What does cardiomyopathy mean? Disease of heart muscle Normal Dilated 1) Muscle cell injury - cell death 2) Chamber enlarges 3) Walls become thin 4) Scar formation or fibrosis 5) Function declines

Cardiomyopathy DMD heart showing evidence of extensive fibrosis.

There are differences between skeletal and cardiac muscle Skeletal muscle Elongated multi-nucleated cells Organized into fascicles Multiple nuclei located on the periphery of the cell Cardiac muscle Rectangular shape Mono-nucleated or bi-nucleated Nuclei located centrally in the cell Often branched Important to note: Not every neuromuscular disorder manifests both skeletal and cardiac disease Skeletal muscle Cardiac muscle

There are differences between skeletal and cardiac muscle Cellular architecture Calcium handling Regenerative capacity When injured: Skeletal muscle regenerates from fusion of mononucleated myoblasts to the syncytium of the myofiber Cardiac muscle limited regenerative capacity injury results in increased connective tissue or scar....

2. What does Heart Failure mean? Complicated The heart fails to meet the demands of the body Does NOT mean the heart has failed (stopped working) Heart failure typically occurs when cardiac function is poor but can occur with good function and increased demand Body s response at first helpful but eventually causes harm PEOPLE LIVE WITH LONG LIVES WITH HEART FAILURE

3. Who should care for the heart? Cardiologist is a heart doctor Pediatric cardiologists Pediatrics and cardiology Adult cardiologists Adult medicine and cardiology Some cardiologists have special interests Heart failure/transplantation Neuromuscular disorders Talk to your sons doctor about finding an expert in treating heart failure

4. When should care begin?

4. When should cardiac care begin? Summary of Consensus Statements Cardiac investigation should: Begin at diagnosis Repeat investigation: At least biannually until age 10 Or with the onset of cardiac signs and symptoms Annually after the age of 10 Or more frequently based on cardiac signs and symptoms Prior to any major surgery Minimum recommendations generated by interested individuals....

5. How will the heart be checked? 1. Electrocardiogram -(ECG) a. Heart Rate b. Heart Rhythm 2. Holter monitor 3. Event monitor Electrocardiogram (ECG) Holter or Event Monitor....

Electrocardiogram (ECG) Abnormal at an early age Early abnormality not predictive of phenotype Type of abnormality changes with age Likely represents disease progression HR often elevated 10-15 bpm above normal True tachycardia (>95 th %ile)comes with dysfunction Important to watch for changes with time Baseline important to obtain at diagnosis % Abnormal ECG 100 80 60 40 20 0 53 67 75 84 91 < 5 5-10 10-15 15-20 20+ Age in years N = 105 ECGs 503

Typical DMD ECG

Holter findings in DMD patient....

5. How will the heart be checked? Images of the heart will be attained to evaluate structure and function

5. How will the heart be checked? Two common ways to obtain images of the heart: Echocardiogram Cardiac MRI....

5. How will the heart be checked? Echocardiogram Ultrasound evaluation of heart Evaluate anatomy and function Contraction (systole) Relaxation (diastole) Advantages: Readily available Quick Disadvantages: Image quality unreliable Scoliosis Weight and position Not accurate for RV function

5. How will the heart be checked? Cardiac MRI Advantages: No radiation exposure Detailed cardiac information Accurate measurements Additional information Fibrosis Metabolism Disadvantages: May involve IV placement One hour in duration Claustrophobic Expensive Sedation (younger children)

5. How will the heart be checked? MRI allows you to obtain information about: Cardiac function Left ventricular ejection fraction In DMD does not decline until late in the disease Left ventricular morphology DMD is not a true dilated cardiomyopathy Normal LV remodeling index at end stage with only modest chamber enlargement....

5. How will the heart be checked? Left ventricular myocardial tissue characterization Evidence of left ventricular non-compaction (LVNC) Unlikely primary LVNC but likely represents disease progression Utilize late gadolinium enhancement for myocardial fibrosis/scar Fibrosis in DMD is sub-epicardial and subendocardial in ischemic cardiomyopathy Left ventricular mechanics Myocardial tagging for myocardial strain analysis....

MRI delayed enhancement and fibrosis MRI short axis view of the left ventricle utilizing Gadolinium delayed enhancement A. DMD 9 year old normal diastolic and systolic function and no fibrosis B. Dystrophinopathy extensive ring of subepimyocardial or midwall fibrosis (arrow) C. Subendomyocardial fibrosis (arrows) associated with ischemic heart disease.... (A. performed at CCHMC; B. Heart, 2004; C. JACC, 2005)

6. What signs and symptoms should I watch for? Know your sons baseline Learn to take his pulse At rest While busy Sleeping Buy a stethoscope Develop a relationship with your care provider before you need them

6. What signs and symptoms should I watch for? Heart failure symptoms often are difficult to identify in DMD patient Rapid weight gain (or loss) Swelling of feet or overall puffiness Heart racing/skipping beats or fainting (syncope) Chest pain (common) Usually musculoskeletal Coronary occlusion Myocarditis Check cardiac enzymes consider additional imaging

7. What treatment is available? Currently, standard HF treatment Taken from adult HF experience Treatment Not based on pediatric data Not dystrophin specific Goals: Improve survival Slow disease Alleviate symptoms....

7. What treatment is available? Standard HF drugs ACE inhibitors enalapril, lisinopril, perindopril Angiotensin- receptor blockers Losartan β-blockers metoprolol, carvedilol Diuretics furosemide, thiazides Aldosterone receptor antagonists Spironolactone, eplerenone Anti-coagulation Coumadin, Aspirin.... NEJM 2003

7. What treatment is available-when to start? We know patient will develop cardiac dysfunction at diagnosis Should cardiac meds be started at dx? No data exists to suggest benefit Families exert significant pressure to do something Start ACE inhibitors when evidence of Left ventricular enlargement Ventricular dysfunction Myocardial fibrosis

Do steroids benefit the heart in DMD?....

7. What treatment is available? Steroids Started early in disease Use dependent on institution Use dependent on country Has been shown to change the time course of the disease Mechanism unknown More than simply the antiinflammatory effect Side effects Hypertension Obesity Delayed puberty Behavioral problems Short stature

Steroid Treatment....

7. What treatment is available? At end stage HF Continuous IV milrinone Cardiac Transplantation Few DMD patients transplanted More BMD patients transplanted Problems Limited donor availability Trading one disease for another Quality of life issues

7. What treatment is available? Ventricular Assist Devices Cutting edge technology Many devices currently under development Possible benefit for subpopulation of DMD/BMD patients Useful as Bridge to transplantation Destination therapy

7. What treatment is available? Pacemakers Cardiac re-synchronization therapy Successful in adult heart failure population Preliminary data suggest DMD population may not be good candidates No evidence of dys-synchrony

7. What treatment is available? Always a risk/benefit analysis If there is abnormal function (+/- symptoms) Benefits established Normal function unclear Role for research to answer: when, what agent, what dose, how long? Risks: All drugs have side effects Drugs untested in patients with DMD....

8. Should carriers have their hearts checked? Often cardiac disease only manifestation Cardiomyopathy risk increases with age Approximately 350 DMD/BMD carriers age < 16 yrs: all normal age 16-30 yrs: 6%; 31-50 yrs: 9%; > 50 yrs: 16% DCM Baseline evaluation as young adult Frequency unclear (? every 5 years) Be aware of symptoms Take care of yourself minimize other CV risks smoking, HTN, cholesterol....

Conclusions Cardiac evaluation should begin at diagnosis

Conclusions Ongoing cardiac follow-up is important and the best way to insure long term cardiac health

Conclusions When there is evidence of abnormal function treatment is recommended

Conclusions Early treatment prior to onset of dysfunction is unproven and controversial Important to consider risks and benefits

Conclusions Need to use common sense AT ALL TIMES

Conclusions Maintain an open dialog with all care providers They are working FOR YOU

Conclusions YOU AND YOUR FAMILY are the most important members of the health care team

THANK YOU